Archives

Shields Health Solutions and Sharp HealthCare Partner to Enhance Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and Sharp HealthCare Partner to Enhance Specialty Pharmacy Services

STOUGHTON, Mass. & SAN DIEGO–(BUSINESS WIRE)–Shields Health Solutions¬†(Shields), the premier specialty pharmacy accelerator in the country, announced today that it has partnered with Sharp HealthCare (Sharp), a not-for-profit regional healthcare…

Shields RA Outcomes 216 115 Shields Health Solutions

Shields RA Outcomes

RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.

Shields MS Outcomes 216 115 Shields Health Solutions

Shields MS Outcomes

MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body

Shields Hep-C Outcomes 216 115 Shields Health Solutions

Shields Hep-C Outcomes

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology

This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
HIV Viral Load Suppression in Patients Utilizing an Integrated Health System Specialty Pharmacy Compared to a Non Integrated Specialty Pharmacy Model 216 115 Shields Health Solutions

HIV Viral Load Suppression in Patients Utilizing an Integrated Health System Specialty Pharmacy Compared to a Non Integrated Specialty Pharmacy Model

This poster highlights that among patients evaluated at UMass Memorial HIV Clinic, those filling ARV medications at the HSSP exhibited higher rates of viral suppression in comparison to patients utilizing…

Clinical Outcomes in Rheumatoid Arthritis Patients Enrolled in an Integrated Specialty Pharmacy Care Model 216 115 Shields Health Solutions

Clinical Outcomes in Rheumatoid Arthritis Patients Enrolled in an Integrated Specialty Pharmacy Care Model

The poster highlights successful therapy responses in Rheumatoid arthritis patients within an integrated HSSP program, employing measures like RAPID3 and absenteeism data to improve disease management and quality of life.…

Impact of an Integrated Health System Specialty Pharmacy on HIV Clinical Outcomes 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy on HIV Clinical Outcomes

This poster highlights our collaboration with Proprium Pharmacy and how the HSSP model consistently improves HIV clinical outcomes, regardless of factors like age, gender, time on service, race/ethnicity, or insurance.…

Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies 216 115 Shields Health Solutions

Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies

This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications…

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network 216 115 Shields Health Solutions

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network

This poster highlights how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating the potential for avoidable medical events. Implementing an integrated care model with…